(1) As used in this section, ‘generic drug’ means:

Terms Used In Oregon Statutes 646A.697

  • Fraud: Intentional deception resulting in injury to another.
  • United States: includes territories, outlying possessions and the District of Columbia. See Oregon Statutes 174.100

(a) A retail drug that is marketed or distributed in accordance with an abbreviated new drug application approved under 21 U.S.C. § 355(j);

(b) An authorized generic as defined by 42 C.F.R. § 447.502; or

(c) A drug that entered the market before 1962 that was not originally marketed under a new drug application.

(2) The Prescription Drug Affordability Board shall annually conduct a study of the operation of the United States market for generic drugs, both drugs dispensed by pharmacists and drugs administered by physicians, including:

(a) The prices of generic drugs on a year-to-year basis;

(b) The degree to which generic drug prices affect insurance premiums;

(c) Annual changes in health insurance cost-sharing for generic drugs;

(d) The potential for and history of generic drug shortages;

(e) The degree to which generic drug prices affect annual spending in the state medical assistance program; and

(f) Any other topic the board considers relevant to the cost of generic drugs.

(3) No later than June 1 of each calendar year, the board shall report to the Legislative Assembly the findings of the board’s study in the manner provided in ORS § 192.245. [2021 c.598 § 6]

 

MORTGAGE RESCUE FRAUD PREVENTION ACT

 

(Foreclosure Consultants)

 

  Previous section
Next section  
 Prescription Drug Affordability Board Contents